Endoret® (PRGF®) technology by BTI Biotechnology Institute is based on the preparation of 100% autologous platelet-rich plasma, which when applied to damaged tissue speeds up the regeneration of a large number of tissues without any adverse effects. Plasma rich in growth factors Endoret® (PRGF®) is the first 100% autologous platelet-rich plasma to be described in literature worldwide and offers a personalised technology that has revolutionised the field of regenerative medicine. Over 20 years of research led to its exclusive properties and make Endoret® (PRGF®) a unique solution. It is prepared using small volumes of the patient's blood and does not require the use of thrombin or chemical agents for its activation.
Unlike other products, it does not include white blood cells (leukocytes) in its composition, which gives it more effective anti-inflammatory properties. Endoret® (PRGF®) is the most versatile technology, as its multiple formulations offer a large number of therapeutic applications from oral and maxillofacial surgery to dermatology, cosmetics, orthopaedic surgery and sports medicine, and more recently to ophthalmology.